Chris Bravery

Company: Consulting on Advanced Biologicals

Job title: Director

Seminars:

Unravelling the Regulatory Roadmap for Allogeneic Products 2:00 pm

• Recent guideline changes in Europe to inform on clinical trial design and data requirements  • How new cell and gene therapy comparability guidelines may impact process changes during development  • Global differences in data requirements for the transition from preclinical to clinical trials Read more

day: Day Two

Unravelling the Regulatory Roadmap for Allogeneic Products to Pave the Route to Commercial Success 9:31 am

Having a clear understanding of current regulations for preclinical, clinical and CMC is essential in the progression of your allogeneic products and therapies. In this regulatory workshop hear about new regulations and changes from experts from regulatory bodies across Europe and have your burning questions answered by these key players. This workshop will cover: •…Read more

day: Pre-Conference Day